Abstract:Obesity-associated metabolic abnormalities comprise a cluster of conditions including dyslipidemia, insulin resistance, diabetes and cardiovascular diseases that has affected more than 650 million people all over the globe. Obesity results from the accumulation of white adipose tissues mainly due to the chronic imbalance of energy intake and energy expenditure. A variety of approaches to treat or prevent obesity, including lifestyle interventions, surgical weight loss procedures and pharmacological approaches to reduce energy intake and increase energy expenditure have failed to substantially decrease the prevalence of obesity. Brown adipose tissue (BAT), the primary source of thermogenesis in infants and small mammals may represent a promising therapeutic target to treat obesity by promoting energy expenditure through non-shivering thermogenesis mediated by mitochondrial uncoupling protein 1 (UCP1). Since the confirmation of functional BAT in adult humans by several groups, approximately a decade ago, and its association with a favorable metabolic phenotype, intense interest on the significance of BAT in adult human physiology and metabolic health has emerged within the scientific community to explore its therapeutic potential for the treatment of obesity and metabolic diseases. A substantially decreased BAT activity in individuals with obesity indicates a role for BAT in the setting of human obesity. On the other hand, BAT mass and its prevalence correlate with lower body mass index (BMI), decreased age and lower glucose levels, leading to a lower incidence of cardio-metabolic diseases. The increased cold exposure in adult humans with undetectable BAT was associated with decreased body fat mass and increased insulin sensitivity. A deeper understanding of the role of BAT in human metabolic health and its interrelationship with body fat distribution and deciphering proper strategies to increase energy expenditure, by either increasing functional BAT mass or inducing white adipose browning, holds the promise for possible therapeutic avenues for the treatment of obesity and associated metabolic disorders.

Browning of Adipocytes: A Potential Therapeutic Approach to Obesity

Brown Adipose Tissue and Regulation of Human Body Weight

Econutrition, Brown And Beige Fat Tissue And Obesity

Activating Brown Adipose Tissue as an Approach to Combat Obesity

Natural Bioactive Compounds as Potential Browning Agents in White Adipose Tissue

Nutritional Regulation of Human Brown Adipose Tissue

Brown Adipose Tissue and Its Role in Insulin and Glucose Homeostasis

Food Ingredients Involved in White-to-Brown Adipose Tissue Conversion and in Calorie Burning

Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity

Weighing in on the role of brown adipose tissue for treatment of obesity

An update on brown adipose tissue and obesity intervention: Function, regulation and therapeutic implications

Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues

Beiging of white adipose tissue as a therapeutic strategy for weight loss in humans

Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus

A Comprehensive Review on Adipose Thermogenesis Modulation

Brown adipose tissue: endocrine determinants of function and therapeutic manipulation as a novel treatment strategy for obesity

Can Brown Fat Win the Battle Against White Fat?

Many Ways to Rome: Exercise, Cold Exposure and Diet—Do They All Affect BAT Activation and WAT Browning in the Same Manner?

The Dark Side of Browning

An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications

Brown and Brite: The Fat Soldiers in the Anti-obesity Fight